Profile
Nicolai Wagtmann served as Vice President & Head-Inflammation Biology at Novo Nordisk A. He also worked as Chief Scientific Officer & Executive VP at Innate Pharma SA from 2013 to 2016.
He holds a doctorate degree from the University of Copenhagen.
Former positions of Nicolai Wagtmann
| Companies | Position | End |
|---|---|---|
| INNATE PHARMA | Chief Tech/Sci/R&D Officer | 2016-06-25 |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Training of Nicolai Wagtmann
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Innate Pharma SA
Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Nicolai Wagtmann
















